6533b85dfe1ef96bd12bde99
RESEARCH PRODUCT
Thrombolysis Followed by Apixaban for Massive Pulmonary Embolism and Free-floating Thrombus in Right Ventricle in a Patient with Breast Cancer
Vito PintoSebastiano ScalzoGiorgio MaringhiniFilippo GanciGioacchino CosenzaSergio CannizzaroStefania DavìNicola MorabitoSergio Fasullosubject
thrombolysismedicine.medical_specialtymedicine.medical_treatmentCase Reportheparinright ventricle030204 cardiovascular system & hematologylaw.invention03 medical and health sciences0302 clinical medicineBreast cancerlawInternal medicinemedicineechocardiographyApixabanRadiology Nuclear Medicine and imaging030212 general & internal medicineThrombusbusiness.industrymassive pulmonary embolismThrombolysisHeparinmedicine.diseaseIntensive care unitPulmonary embolismmedicine.anatomical_structureVentricleCardiologyApixabanCardiology and Cardiovascular Medicinebusinessmedicine.drugdescription
Free-floating thrombus in the right ventricle, associated with a massive acute pulmonary embolism (PE), is a rare phenomenon. PE is an important clinical entity with considerable mortality despite advances in diagnosis and treatment. The prognosis of PE depends on right ventricular dysfunction, myocardial injury markers, and early treatment. In this report, we present the case of a 71-year-old woman with a history of breast cancer admitted to intensive care unit for PE complicated by syncope. Although our case may seem complex because it is not represented in the guidelines, the result was satisfactory and showed how treatment with new anticoagulants (in this case apixaban) after massive thrombolysis of PE could be considered and included in the new guidelines.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2018-01-01 | Journal of Cardiovascular Echography |